Filtered By:
Infectious Disease: Coronavirus
Therapy: Radiation Therapy

This page shows you your search results in order of date.

Order by Relevance | Date

Total 19 results found since Jan 2013.

Antibody responses to second doses of COVID-19 vaccination in lung cancer patients undergoing treatment
CONCLUSIONS: Antibody titers after the second vaccination were lower in cancer patients than those in healthy individuals. Our findings provide essential information for understanding the benefits and necessity of additional vaccination to prevent SARS-CoV-2 infection in lung cancer patients.PMID:36567161 | DOI:10.1016/j.resinv.2022.11.005
Source: Cancer Control - December 25, 2022 Category: Cancer & Oncology Authors: Daisuke Narita Risa Ebina-Shibuya Eisaku Miyauchi Yoko Tsukita Ryota Saito Koji Murakami Nozomu Kimura Hisatoshi Sugiura Source Type: research

Imaging of Drug-Related Pneumonitis in Oncology
This article will describe the computed tomography (CT) pattern-based approach for drug-related pneumonitis that has been utilized to describe the imaging manifestations of pneumonitis from novel cancer therapies. Then, we will discuss pneumonitis from representative agents of precision cancer therapy, including mammalian target of rapamycin inhibitors, epidermal growth factor receptor inhibitors, and ICI, focusing on the incidence, risk factors, and the spectrum of CT patterns. Finally, the article will address emerging challenges in the diagnosis and monitoring of pneumonitis, including pneumonitis from combination ICI a...
Source: Respiratory Care - October 28, 2022 Category: Respiratory Medicine Authors: Shu-Chi Tseng Ho Yun Lee Mizuki Nishino Source Type: research

Single-fraction stereotactic ablative body radiation therapy for primary and metastasic lung tumor: A new paradigm?
World J Clin Oncol. 2022 Feb 24;13(2):101-115. doi: 10.5306/wjco.v13.i2.101.ABSTRACTStereotactic ablative body radiotherapy (SABR) is an effective technique comparable to surgery in terms of local control and efficacy in early stages of non-small cell lung cancer (NSCLC) and pulmonary metastasis. Several fractionation schemes have proven to be safe and effective, including the single fraction (SF) scheme. SF is an option cost-effectiveness, more convenience and comfortable for the patient and flexible in terms of its management combined with systemic treatments. The outbreak of the severe acute respiratory syndrome coronav...
Source: Clinical Lung Cancer - March 23, 2022 Category: Cancer & Oncology Authors: Castalia Fern ández Arturo Navarro-Martin Andrea Bobo Joaqu ín Cabrera-Rodriguez Patricia Calvo Rodolfo Chicas-Sett Javier Luna Nuria Rodr íguez de Dios Felipe Cou ñago Source Type: research

Cancers, Vol. 14, Pages 790: Systematic Review of Single-Fraction Stereotactic Body Radiation Therapy for Early Stage Non-Small-Cell Lung Cancer and Lung Oligometastases: How to Stop Worrying and Love One and Done
a Anurag K. Singh Adoption of single-fraction lung stereotactic body radiation therapy (SBRT) for patients with medically inoperable early stage non-small-cell lung cancer (NSCLC) or oligometastatic lung disease, even during the coronavirus disease 2019 (COVID-19) pandemic, was limited despite encouraging phase II trial results. Barriers to using single-fraction SBRT may include lack of familiarity with the regimen and lack of clarity about the expected toxicity. To address these concerns, we performed a systematic review of prospective literature on single-fraction SBRT for definitive treatment of early stage and ol...
Source: Cancers - February 3, 2022 Category: Cancer & Oncology Authors: Austin J. Bartl Mary Mahoney Mark W. Hennon Sai Yendamuri Gregory M. M. Videtic Kevin L. Stephans Shankar Siva Mark K. Farrugia Sung Jun Ma Anurag K. Singh Tags: Systematic Review Source Type: research

Hypofractionated Radiotherapy in Head and Neck Cancer Elderly Patients: A Feasibility and Safety Systematic Review for the Clinician
CONCLUSION: HFRT seems to be a good treatment with an acceptable prolonged disease control. In older patients fit for radical treatments, a 55 Gy in 20 fractions regimen can be proposed as a valid alternative to the standard fractionated RT, but there are a multitude of hypofractionated regimens, ranging from single fraction, quad shot, and 1-, 2-, 3-, 4-, and 5-week schedules that all may be appropriate. The correct regimen for a patient depends on many factors, and it represents the result of a more specific and complex decision.PMID:34868976 | PMC:PMC8633531 | DOI:10.3389/fonc.2021.761393
Source: Cancer Control - December 6, 2021 Category: Cancer & Oncology Authors: Antonio Piras Luca Boldrini Sebastiano Menna Valeria Venuti Gianfranco Pernice Ciro Franzese Tommaso Angileri Antonino Daidone Source Type: research

Impact of the COVID-19 Pandemic on Colorectal Cancer Diagnosis and Treatment: a Systematic Review
ConclusionAccording to the reduction in the diagnosis and treatment of colorectal cancer due to the COVID-19 pandemic, compensating for the reduction and preventing the continuation of this declining trend, requires serious and effective interventions to prevent its subsequent consequences, including referrals of people with advanced stages and emergency conditions, increasing treatment costs and reducing the quality of life and patients  survival.
Source: Journal of Gastrointestinal Cancer - November 29, 2021 Category: Cancer & Oncology Source Type: research

Hypofractionated Radiotherapy in Head and Neck Cancer Elderly Patients: A Feasibility and Safety Systematic Review for the Clinician
ConclusionHFRT seems to be a good treatment with an acceptable prolonged disease control. In older patients fit for radical treatments, a 55 Gy in 20 fractions regimen can be proposed as a valid alternative to the standard fractionated RT, but there are a multitude of hypofractionated regimens, ranging from single fraction, quad shot, and 1-, 2-, 3-, 4-, and 5-week schedules that all may be appropriate. The correct regimen for a patient depends on many factors, and it represents the result of a more specific and complex decision.
Source: Frontiers in Oncology - November 12, 2021 Category: Cancer & Oncology Source Type: research

Emerging Cybersecurity Threats in Radiation Oncology
CONCLUSIONS: Cybersecurity threats continue to evolve, making combatting these attacks more difficult for health care organizations and requiring a change in strategies, tactics, and culture around cyber security in health and radiation oncology. We recommend an assume breach mentality (threat-informed defense posture) and adopting a cloud-first and zero-trust security strategy. A reliance on computer-driven technology makes radiation oncology practices more vulnerable to cyberattacks. Health care providers should increase their resilience and cyber security maturity. The increase in the diversity of these attacks demands ...
Source: Adv Data - November 8, 2021 Category: Epidemiology Authors: Christine Joyce Faustin Laurentiu Roman Brett Miller John Jeffries Robert C Miller Source Type: research

Low-dose radiation therapy for COVID-19 pneumonia: a pilot study
CONCLUSION: The results of our pilot study suggest that LDRT is feasible in COVID-19 patients having moderate to severe disease. Its clinical efficacy may be tested by conducting randomized controlled trials.ADVANCES IN KNOWLEDGE: LDRT has shown promising results in COVID-19 pneumonia and should be researched further through randomized controlled trials.PMID:34545760 | DOI:10.1259/bjr.20210187
Source: The British Journal of Radiology - September 21, 2021 Category: Radiology Authors: Daya Nand Sharma Randeep Guleria Naveet Wig Anant Mohan Goura Rath Vellaiyan Subramani Sushma Bhatnagar Supriya Mallick Aman Sharma Pritee Patil Karan Madan Manish Soneja Sanjay Thulkar Angel Singh Sheetal Singh Source Type: research

NIDCR's Fall 2021 E-Newsletter
Having trouble viewing this email? View it as a Web page. NIDCR's Fall 2021 E-Newsletter In this issue: NIDCR News Funding Opportunities & Related Notices NIH/HHS News Subscribe to NICDR News Science Advances   NIDCR News 5 Q&As About “Oral Health in America: Advances and Challenges” NIDCR issued a brief Q&A regarding details of the forthcoming report Oral Health in America: Advances and Challenges, which will be published in Fall 2021. This comprehensive report will examine improvements in oral health over the past two decades,...
Source: NIDCR Science News - September 1, 2021 Category: Dentistry Source Type: news

Low-dose radiation therapy (LDRT) for COVID-19 and its deadlier variants
Arch Toxicol. 2021 Jul 24. doi: 10.1007/s00204-021-03124-x. Online ahead of print.ABSTRACTCoronavirus variants are gaining strongholds throughout the globe. Despite early signals that SARS-CoV-2 coronavirus case numbers are easing up in the United States and during the middle of a (not so easy) vaccination roll out, the country has passed a grim landmark of 600,000 deaths. We contend that these numbers would have been much lower if the medical community undertook serious investigations into the potential of low doses of radiation (LDRT) as a mainstream treatment modality for COVID-19 pneumonia. LDRT has been posited to man...
Source: Archives of Toxicology - July 24, 2021 Category: Toxicology Authors: Rachna Kapoor James S Welsh Vikas Dhawan Seyed Alireza Javadinia Edward J Calabrese Gaurav Dhawan Source Type: research